Formulary has been developed by the Medicines Optimisation Committee (MOC) of
South Staffordshire & Shropshire Healthcare NHS Foundation Trust and
through consultation with clinicians.
Details of the MOC membership can be found on the Trusts Internet at http://www.sssft.nhs.uk/services/pharmacy. The Formulary represents a collaborative
approach to medicines optimisation between the Trust and its key Primary Care
Aim of the Formulary is to advise clinicians on evidence based drug treatments
(which are cost and clinically effective) and commonly encountered in clinical
Formulary is applicable to all doctors and all Non-Medical Prescribers (NMPs)
whose individual Formularies will be agreed with the Advanced Nurse, Medicines
Optimisation, the NMP and their Designated Medical Practitioner.
vast majority of prescribing in Mental Health both in primary and secondary
care should be covered by this Formulary. The Formulary advises on the appropriate
positioning of drugs in the treatment of mental health conditions. Compliance rates with the Formulary are fed
back at Team level to Clinical Directorates
on a regular basis. On the rare
occasions when In Patient clinicians are required to initiate physical health
medicines please refer to the appropriate primary care Formulary which can be
found at the following web addresses: http://www.southstaffordshirejointformulary.nhs.uk/, http://www.telfordccg.nhs.uk/primary-care-drugs-formulary-, http://www.shropshireccg.nhs.uk/drug-formulary.
drugs should be prescribed generically unless a particular preparation needs to
be specified because of variations in bioavailability between different brands,
these are identified in the Formulary.
It is recognised that on occasion non-formulary items will be
legitimately requested although in such circumstances Pharmacists may seek a
rationale from the prescribing clinicians.
Licensed products should be used wherever possible.
is anticipated that this Formulary will evolve through debate and suggestion
and as new drugs become available. Requests
for amendments to the formulary can only be made by psychiatrists and should be
made by submitting the Application to Amend the Formulary Form which can be
accessed from either the netFormulary or at the following web page: http://www.sssft.nhs.uk/services/pharmacy/information-for-professionals/formulary. Genuine ownership of the Formulary by
clinicians in the Trust who prescribe for people with mental health problems
will help to refine it and enhance its relevance to everyday clinical practice.
price banding system has been included; the aim of the banding is to give the
prescribing clinician an idea of the cost.
The costs have been calculated using the May 16 Drug Tariff prices with
the exception of the Inclusion section which uses the December 17 Drug Tariff
prices (the cost to primary care). Prices are for oral, immediate release
preparations, 28 days supply at the highest BNF dose. Clinicians should note from this information
that differences between formulations of the same drug can be significant as
medicines come off Patent e.g. XL formulations, patches, orodispersible
drug has been colour coded: green means any clinician can prescribe, amber means it is appropriate for all
clinicians but must be initiated by a specialist and the patient stabilised
before shared care is considered & red means
specialist services only.
Shared Care Agreements or Best Practice Guidelines have been agreed for deployment in certain areas, they
can be found on netFormulary or the Trusts website at http://www.sssft.nhs.uk/services/pharmacy/information-for-professionals/essential-shared-care-agreements-escas.
National Patient Safety Agency has published a Reduction of Self Harm and High
Risk Drugs, which can be found on the Trusts website at: http://www.sssft.nhs.uk/services/pharmacy/information-for-professionals/high-risk-drugs-list.
The Royal College of General Practitioners and Secure
Environments Pharmacists Group have published guidance on Safer Prescribing in
Prison, which can be found at http://www.rcgp.org.uk/clinical-and-research/clinical-resources/~/media/106D28C849364D4CB2CB5A75A4E0849F.ashx.